Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biomed Res Int ; 2021: 5746629, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34697588

RESUMEN

Entamoeba histolytica is the causative agent of amoebiasis, and Entamoeba dispar is its noninvasive morphological twin. Entamoeba invadens is a reptilian parasite. In the present study, Western blot, phosphatase activity, immunofluorescence, and bioinformatic analyses were used to identify PP2C phosphatases of E. histolytica, E. dispar, and E. invadens. PP2C was identified in trophozoites of all Entamoeba species and cysts of E. invadens. Immunoblotting using a Leishmania mexicana anti-PP2C antibody recognized a 45.2 kDa PP2C in all species. In E. histolytica and E. invadens, a high molecular weight element PP2C at 75 kDa was recognized, mainly in cysts of E. invadens. Immunofluorescence demonstrated the presence of PP2C in membrane and vesicular structures in the cytosol of all species analyzed. The ~75 kDa PP2C of Entamoeba spp. shows the conserved domain characteristic of phosphatase enzymes (according to in silico analysis). Possible PP2C participation in the encystation process was discussed.


Asunto(s)
Entamoeba/enzimología , Proteína Fosfatasa 2C/metabolismo , Proteínas Protozoarias/metabolismo , Trofozoítos/enzimología , Secuencia de Aminoácidos , Animales , Entamoeba/aislamiento & purificación , Entamebiasis/parasitología , Entamebiasis/patología , Humanos , Filogenia , Proteína Fosfatasa 2C/química , Proteína Fosfatasa 2C/genética , Proteínas Protozoarias/química , Proteínas Protozoarias/genética , Homología de Secuencia de Aminoácido , Trofozoítos/aislamiento & purificación
2.
Mol Biochem Parasitol ; 242: 111360, 2021 03.
Artículo en Inglés | MEDLINE | ID: mdl-33428948

RESUMEN

The Entamoeba histolytica parasite is the causative agent of amebiasis, infecting approximately 1% of the world population and causing 100,000 deaths per year. It binds to Fibronectin (FN), activating signaling pathways regulated by kinases and phosphatases. EhLMW-PTPs genes from E. histolytica encode for Low Molecular Weight Tyrosine Phosphatases expressed in trophozoites and amoebic cysts. The role of these phosphatases in the virulence of the parasite has not yet been well characterized. Our results showed a differential expression of the EhLMW-PTPs, at the mRNA and protein levels, in an asynchronous trophozoites culture. Furthermore, we observed that trophozoites transfected that overexpressed EhLMW-PTP2 phagocytized fewer erythrocytes, possibly due to decreased phagocytic cups, and showed deficiencies in adherence to FN and less cytopathic effect. These analyzes suggest that the parasite's EhLMW-PTPs have an essential role in the mechanisms of proliferation, adhesion, and phagocytosis, regulating its pathogenicity.


Asunto(s)
Entamoeba histolytica/patogenicidad , Proteínas Tirosina Fosfatasas/genética , Proteínas Protozoarias/genética , Trofozoítos/patogenicidad , Factores de Virulencia/genética , Animales , Células CACO-2 , Adhesión Celular , Proliferación Celular , Clonación Molecular , Técnicas de Cocultivo , Entamoeba histolytica/enzimología , Entamoeba histolytica/genética , Eritrocitos/citología , Escherichia coli/genética , Escherichia coli/metabolismo , Femenino , Fibronectinas/química , Fibronectinas/metabolismo , Expresión Génica , Vectores Genéticos/química , Vectores Genéticos/metabolismo , Humanos , Ratones , Ratones Endogámicos BALB C , Peso Molecular , Fagocitosis/fisiología , Proteínas Tirosina Fosfatasas/metabolismo , Proteínas Tirosina Fosfatasas/farmacología , Proteínas Protozoarias/metabolismo , Proteínas Protozoarias/farmacología , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacología , Trofozoítos/enzimología , Trofozoítos/genética , Virulencia , Factores de Virulencia/metabolismo , Factores de Virulencia/farmacología
3.
Biochimie ; 180: 43-53, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33122104

RESUMEN

Entamoeba histolytica is an intestinal protozoan parasite of humans and is endemic in developing countries. E. histolytica has two low molecular weight protein tyrosine phosphatase (LMW-PTP) genes, EhLMW-PTP1 and EhLMW-PTP2, which are expressed in cultured trophozoites, clinical isolates, and cysts. The amino acid sequences of proteins EhLMW-PTP1 and EhLMW-PTP2 showed only one amino acid difference between them at position A85V, respectively. Both genes are expressed in cultured trophozoites, mainly EhLMW-PTP2, and in trophozoites recovered from amoebic liver abscess, the expression of EhLMW-PTP1 is downregulated. We cloned the two genes and purified the corresponding recombinant (rEhLMW-PTPs) proteins. Antibodies anti-rEhLMW-PTP2 showed that during red blood cells uptake by E. histolytica, the EhLMW-PTPs were found in the phagocytic cups based on analysis of fluorescence signals. On the other hand, rEhLMW-PTPs showed an optimum phosphatase activity at pH 6.0 with p-nitrophenyl phosphate as the substrate. They dephosphorylate phosphotyrosine and 3-O-methylfluorescein phosphate, but not phosphoserine or phosphothreonine, and the enzymatic activity is inhibited by orthovanadate. rEhLMW-PTP1 and rEhLMW-PTP2 exhibited optimum temperatures of activities at 60 °C and 58 °C, respectively, with high thermal stability at 50 °C. Also, the rEhLMW-PTPs showed high specific activities and specific km value with pNPP or OMFP as the substrates at the physiological temperature (37 °C).


Asunto(s)
Entamoeba histolytica/enzimología , Absceso Hepático Amebiano/enzimología , Proteínas Tirosina Fosfatasas/química , Proteínas Tirosina Fosfatasas/metabolismo , Secuencia de Aminoácidos , Animales , Quelantes/farmacología , Cricetinae , Entamoeba histolytica/genética , Inhibidores Enzimáticos/farmacología , Estabilidad de Enzimas , Eritrocitos/parasitología , Femenino , Humanos , Concentración de Iones de Hidrógeno , Absceso Hepático Amebiano/genética , Ratones Endogámicos BALB C , Peso Molecular , Proteínas Tirosina Fosfatasas/antagonistas & inhibidores , Proteínas Tirosina Fosfatasas/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/efectos de los fármacos , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Especificidad por Sustrato , Temperatura , Trofozoítos/citología , Trofozoítos/enzimología , Trofozoítos/genética
4.
Int J Parasitol ; 50(12): 1011-1022, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32822677

RESUMEN

Epigenetic mechanisms such as histone acetylation and deacetylation participate in regulation of the genes involved in encystation of Entamoeba invadens. However, the histones and target residues involved, and whether the acetylation and deacetylation of the histones leads to the regulation of gene expression associated with the encystation of this parasite, remain unknown. In this study, we found that E. invadens histone H4 is acetylated in both stages of the parasite and is more highly acetylated during the trophozoite stage than in the cyst. Histone hyperacetylation induced by Trichostatin A negatively affects the encystation of E. invadens, and this inhibition is associated with the downregulation of the expression of genes implicated in the synthesis of chitin, polyamines, gamma-aminobutyric acid pathways and cyst wall proteins, all of which are important in the formation of cysts. Finally, in silico analysis and activity assays suggest that a class I histone deacetylase (EiHDAC3) could be involved in control of the expression of a subset of genes that are important in several pathways during encystation. Therefore, the identification of enzymes that acetylate and/or deacetylate histones that control encystation in E. invadens could be a promising therapeutic target for preventing transmission of other amoebic parasites such as E. histolytica, the causative agent of amoebiasis in humans.


Asunto(s)
Entamoeba , Histona Desacetilasas/metabolismo , Animales , Quitina/metabolismo , Entamoeba/enzimología , Humanos , Procesamiento Proteico-Postraduccional , Trofozoítos/enzimología
5.
Parasitol Res ; 119(8): 2587-2595, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32524267

RESUMEN

Lycorine is an Amaryllidaceae alkaloid that presents anti-Trichomonas vaginalis activity. T. vaginalis causes trichomoniasis, the most common non-viral sexually transmitted infection. The modulation of T. vaginalis purinergic signaling through the ectonucleotidases, nucleoside triphosphate diphosphohydrolase (NTPDase), and ecto-5'-nucleotidase represents new targets for combating the parasite. With this knowledge, the aim of this study was to investigate whether NTPDase and ecto-5'-nucleotidase inhibition by lycorine could lead to extracellular ATP accumulation. Moreover, the lycorine effect on the reactive oxygen species (ROS) production by neutrophils and parasites was evaluated as well as the alkaloid toxicity. The metabolism of purines was assessed by HPLC. ROS production was measured by flow cytometry. Cytotoxicity against epithelial vaginal cells and fibroblasts was tested, as well as the hemolytic effect of lycorine and its in vivo toxicity in Galleria mellonella larvae. Our findings showed that lycorine caused ATP accumulation due to NTPDase inhibition. The alkaloid did not affect the ROS production by T. vaginalis; however, it increased ROS levels in neutrophils incubated with lycorine-treated trophozoites. Lycorine was cytotoxic against vaginal epithelial cells and fibroblasts; conversely, it was not hemolytic neither exhibited toxicity against the in vivo model of G. mellonella larvae. Overall, besides having anti-T. vaginalis activity, lycorine modulates ectonucleotidases and stimulates neutrophils to secrete ROS. This mechanism of action exerted by the alkaloid could enhance the susceptibility of T. vaginalis to host immune cell, contributing to protozoan clearance.


Asunto(s)
Alcaloides de Amaryllidaceae/farmacología , Amaryllidaceae/química , Antiprotozoarios/farmacología , Neutrófilos/metabolismo , Nucleósido-Trifosfatasa/antagonistas & inhibidores , Fenantridinas/farmacología , Extractos Vegetales/farmacología , Proteínas Protozoarias/antagonistas & inhibidores , Tricomoniasis/metabolismo , Trichomonas vaginalis/enzimología , 5'-Nucleotidasa/antagonistas & inhibidores , 5'-Nucleotidasa/metabolismo , Humanos , Neutrófilos/efectos de los fármacos , Nucleósido-Trifosfatasa/metabolismo , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Tricomoniasis/parasitología , Trichomonas vaginalis/efectos de los fármacos , Trichomonas vaginalis/crecimiento & desarrollo , Trichomonas vaginalis/metabolismo , Trofozoítos/efectos de los fármacos , Trofozoítos/enzimología , Trofozoítos/crecimiento & desarrollo , Trofozoítos/metabolismo
6.
Biochem Biophys Res Commun ; 524(1): 135-141, 2020 03 26.
Artículo en Inglés | MEDLINE | ID: mdl-31980165

RESUMEN

Entamoeba invadens is the protozoan which causes multiple damages in reptiles and is considered a prototype for the study of the Entamoeba encystment/excystment in vitro. Here we report that EinCerS2 knockdown promoted decrease in sphingomyelin (SM) subspecies with long-chain fatty acids (24:0) down to 50% but increase sphingolipids with short-chain fatty acids (16:0) up to three times in both trophozoites and cysts of E. invadens. EinCerS2 silencing also resulted in decreased trophozoites' movement, proliferation, cysts formation, and trophozoites hatched after excystment. By immunofluorescence assays, a polyclonal antibody against EinCerS2 detected the enzyme in the cytoplasm of E. invadens trophozoites, colocalizing with Endoplasmic Reticulum-resident cognate EiSERCA. Interestingly, EinCerS2 was redistributed close to the plasma membrane during encystation, suggesting that the generation of diacylglycerol (DAG) via synthesis of sphingolipids and the activation protein kinase C might participate in the encystment process of E. invadens.


Asunto(s)
Movimiento Celular , Entamoeba/citología , Entamoeba/enzimología , Técnicas de Silenciamiento del Gen , Oxidorreductasas/metabolismo , Trofozoítos/enzimología , Trofozoítos/crecimiento & desarrollo , Proliferación Celular , Supervivencia Celular , Regulación hacia Abajo/genética , Entamoeba/genética , Amplificación de Genes , Estadios del Ciclo de Vida , Oxidorreductasas/genética , Transporte de Proteínas , ARN Mensajero/genética , ARN Mensajero/metabolismo , Esfingomielinas/metabolismo
7.
Mol Biochem Parasitol ; 228: 16-26, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30658179

RESUMEN

Giardia lamblia is one of the most common protozoan infectious agents in the world and is responsible for diarrheal disease and chronic postinfectious illness. During the host-parasite interaction, proteases are important molecules related to virulence, invasion, and colonization, not only for Giardia but also for other parasites. We aimed to characterize the cysteine protease activity detected in trophozoite lysates. This proteolytic activity showed the ability to cleave NH-terminal sequences with either a recognition sequence for a viral protease or a recognition sequence for thrombin. This cleavage activity was detected in nonencysting trophozoites and increased with the progression of encystation. This activity was also detected in excretion/secretion products of axenic trophozoites and in trophozoites cocultured with differentiated Caco-2 cells. Based on size exclusion chromatography, we obtained a fraction enriched in low- to medium-molecular-weight proteins that was capable of exerting this cleavage activity and aggregating human platelets. Finally, our results suggest that this proteolytic activity is shared with other protozoan parasites.


Asunto(s)
Proteasas de Cisteína/metabolismo , Giardia lamblia/enzimología , Proteínas Protozoarias/metabolismo , Células CACO-2 , Catepsina B/química , Catepsina B/genética , Catepsina B/metabolismo , Proteasas de Cisteína/química , Proteasas de Cisteína/genética , Giardia lamblia/química , Giardia lamblia/genética , Giardiasis , Humanos , Proteolisis , Proteínas Protozoarias/química , Proteínas Protozoarias/genética , Especificidad por Sustrato , Trofozoítos/química , Trofozoítos/enzimología , Trofozoítos/genética
8.
Colloids Surf B Biointerfaces ; 173: 725-732, 2019 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-30384269

RESUMEN

Acanthamoeba keratitis is an ophthalmic disease with no specific treatment that specially affects contact lens users. The silencing of serine phosphatase (SP) and glycogen phosphorylase (GP) proteins produced by Acanthamoeba has been shown to significantly reduce the cytopathic effect, although no vehicle was proposed yet to deliver the siRNA sequences to the trophozoites. In this study, PEGylated cationic liposomes were proposed and optimized using Box-Behnken design. The influence of DOTAP:DOPE ratio, DSPE-PEG concentration, and siRNA/DOTAP charge ratio were evaluated over both biological response and physicochemical properties of liposomes. The ratio of DOTAP:DOPE had an effect in the trophozoite activity whereas the charge ratio influenced both size and protease activity. The predicted values were very close to the observed values, yielding a formulation with good activity and toxicity profile, which was used in the following experiments. A murine model of ocular keratitis was treated with siGP + siSP-loaded liposomes, as well as their respective controls, and combined treatment of liposomes and chlorhexidine. After 15 days of eight daily administrations, the liposomal complex combined with chlorhexidine was the only treatment able to reverse the more severe lesions associated with keratitis. There was 60% complete regression in corneal damage, with histological sections demonstrating the presence of an integral epithelium, without lymphocytic infiltrate. The set of results demonstrate the efficacy of a combined therapy based on siRNA with classical drugs for a better prognosis of keratitis caused by Acanthamoeba.


Asunto(s)
Queratitis por Acanthamoeba/terapia , Acanthamoeba/efectos de los fármacos , Clorhexidina/farmacología , Sistemas de Liberación de Medicamentos/métodos , Liposomas/química , Proteínas Protozoarias/antagonistas & inhibidores , Trofozoítos/efectos de los fármacos , Acanthamoeba/enzimología , Acanthamoeba/patogenicidad , Queratitis por Acanthamoeba/parasitología , Queratitis por Acanthamoeba/patología , Animales , Córnea/efectos de los fármacos , Córnea/parasitología , Córnea/patología , Modelos Animales de Enfermedad , Esquema de Medicación , Composición de Medicamentos/métodos , Quimioterapia Combinada , Análisis Factorial , Ácidos Grasos Monoinsaturados/química , Regulación de la Expresión Génica , Glucógeno Fosforilasa/antagonistas & inhibidores , Glucógeno Fosforilasa/genética , Glucógeno Fosforilasa/metabolismo , Humanos , Liposomas/metabolismo , Fosfatidiletanolaminas/química , Monoéster Fosfórico Hidrolasas/antagonistas & inhibidores , Monoéster Fosfórico Hidrolasas/genética , Monoéster Fosfórico Hidrolasas/metabolismo , Polietilenglicoles/química , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Compuestos de Amonio Cuaternario/química , ARN Interferente Pequeño/genética , ARN Interferente Pequeño/metabolismo , Ratas , Ratas Wistar , Trofozoítos/enzimología , Trofozoítos/patogenicidad
9.
Parasitol Res ; 117(10): 3205-3214, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30043281

RESUMEN

Giardia intestinalis is a protozoan parasite that colonizes the upper part of the small intestine of its mammalian hosts. The trophozoite, which is the replicative stage, has a complex cytoskeleton that allows it to move and adhere to intestinal cells. It has been proposed that protein phosphatase 2A (PP2A) participates in the regulation of changes to the parasite cytoskeleton during its life cycle. However, how PP2A is involved in this regulation remains unclear since its substrates and regulators have not been characterized. In this work, we report the bioinformatic and experimental analysis of two potential regulatory B″ subunits of PP2A in Giardia, both of which are calcium-binding proteins. In this work, in silico and experimental evidence of the binding of both proteins to calcium is presented; the proteins are shown to interact with the catalytic PP2A subunit in the trophozoite stage, and they exhibit different subcellular localization patterns. Because PP2A is a heterotrimer, homology analysis of the different subunits of PP2A indicates that fewer holoenzyme combinations can be formed in this parasite than in other organisms. Our results suggest that the localization of PP2A may be associated with calcium-dependent signaling through its B″ type regulatory subunits.


Asunto(s)
Proteínas de Unión al Calcio/metabolismo , Giardia lamblia/metabolismo , Proteína Fosfatasa 2/química , Proteína Fosfatasa 2/metabolismo , Proteínas Protozoarias/química , Proteínas Protozoarias/metabolismo , Trofozoítos/enzimología , Animales , Calcio/metabolismo , Proteínas de Unión al Calcio/química , Proteínas de Unión al Calcio/genética , Dominio Catalítico , Giardia lamblia/enzimología , Giardia lamblia/genética , Proteína Fosfatasa 2/genética , Subunidades de Proteína , Proteolisis , Proteínas Protozoarias/genética , Trofozoítos/química , Trofozoítos/genética , Trofozoítos/metabolismo
10.
Biochem J ; 474(23): 4001-4017, 2017 11 21.
Artículo en Inglés | MEDLINE | ID: mdl-29054977

RESUMEN

Despite its importance in the regulation of growth and differentiation processes of a variety of organisms, the mechanism of synthesis and degradation of cAMP (cyclic AMP) has not yet been described in Giardia lamblia In this work, we measured significant quantities of cAMP in trophozoites of G. lamblia incubated in vitro and later detected how it increases during the first hours of encystation, and how it then returns to basal levels at 24 h. Through an analysis of the genome of G. lamblia, we found sequences of three putative enzymes - one phosphodiesterase (gPDE) and two nucleotidyl cyclases (gNC1 and gNC2) - that should be responsible for the regulation of cAMP in G. lamblia Later, an RT-PCR assay confirmed that these three genes are expressed in trophozoites. The bioinformatic analysis indicated that gPDE is a transmembrane protein of 154 kDa, with a single catalytic domain in the C-terminal end; gNC1 is predicted to be a transmembrane protein of 74 kDa, with only one class III cyclase homology domain (CHD) at the C-terminal end; and gNC2 should be a transmembrane protein of 246 kDa, with two class III CHDs. Finally, we cloned and enriched the catalytic domain of gNC1 (gNC1cd) from bacteria. After that, we confirmed that gNC1cd has adenylyl cyclase (AC) activity. This enzymatic activity depends on the presence of Mn2+ and Ca2+, but no significant activity was displayed in the presence of Mg2+ Additionally, the AC activity of gNC1cd is competitively inhibited with GTP, so it is highly possible that gNC1 has guanylyl cyclase activity as well.


Asunto(s)
Adenilil Ciclasas/química , AMP Cíclico/química , Giardia lamblia/enzimología , Guanilato Ciclasa/química , Hidrolasas Diéster Fosfóricas/química , Proteínas Protozoarias/química , Adenilil Ciclasas/genética , Adenilil Ciclasas/metabolismo , Secuencia de Aminoácidos , Calcio/química , Calcio/metabolismo , Dominio Catalítico , Clonación Molecular , Cristalografía por Rayos X , AMP Cíclico/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Expresión Génica , Giardia lamblia/genética , Giardia lamblia/crecimiento & desarrollo , Guanilato Ciclasa/genética , Guanilato Ciclasa/metabolismo , Cinética , Manganeso/química , Manganeso/metabolismo , Modelos Moleculares , Hidrolasas Diéster Fosfóricas/genética , Hidrolasas Diéster Fosfóricas/metabolismo , Plásmidos/química , Plásmidos/metabolismo , Unión Proteica , Dominios y Motivos de Interacción de Proteínas , Estructura Secundaria de Proteína , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Alineación de Secuencia , Homología Estructural de Proteína , Especificidad por Sustrato , Trofozoítos/enzimología , Trofozoítos/genética , Trofozoítos/crecimiento & desarrollo
11.
Nat Commun ; 8(1): 101, 2017 07 17.
Artículo en Inglés | MEDLINE | ID: mdl-28740237

RESUMEN

The protozoan parasite Entamoeba histolytica is the aetiologic agent of amoebiasis, an endemic infection in developing countries with considerable morbidity and mortality. Recently, trogocytosis has been recognized as the key step in amoebic cytolysis and invasion, a paradigm shift in understanding pathogenicity of this organism. Here we report that AGC family kinase 1 is specifically involved in trogocytosis of live human cells and does not participate in phagocytosis of dead cells. Live imaging reveals localization of this kinase in the long and thin tunnels formed during trogocytosis but not in the trogosomes (endosomes formed after trogocytosis). Silencing of the specific gene leads to a defect in CHO cell destruction and trogocytosis while other endocytic processes remain unaffected. The results suggest that the trogocytic pathway is likely to be different from phagocytosis though many of the steps and molecules involved may be common. Entamoeba histolytica can kill host cells by trogocytosis, while it ingests dead cells by phagocytosis. Here, Somlata et al. show that EhAGCK1, an AGC family kinase, is specifically involved in trogocytosis, shedding light on the molecular differences between trogocytosis and phagocytosis.


Asunto(s)
Entamoeba histolytica/enzimología , Familia de Multigenes/fisiología , Secuencia de Aminoácidos , Clonación Molecular , Entamoeba histolytica/metabolismo , Regulación Enzimológica de la Expresión Génica , Silenciador del Gen , Familia de Multigenes/genética , Fagocitosis , Fosfatidilinositol 3-Quinasas/genética , Fosfatidilinositol 3-Quinasas/metabolismo , Unión Proteica , Dominios Proteicos , Trofozoítos/enzimología , Trofozoítos/metabolismo
12.
Sci Rep ; 6: 33189, 2016 09 12.
Artículo en Inglés | MEDLINE | ID: mdl-27616047

RESUMEN

Malaria is a life-threatening disease caused by different species of the protozoan parasite Plasmodium, with P. falciparum being the deadliest. Increasing parasitic resistance to existing antimalarials makes the necessity of novel avenues to treat this disease an urgent priority. The enzymes responsible for the synthesis of phosphatidylcholine and phosphatidylethanolamine are attractive drug targets to treat malaria as their selective inhibition leads to an arrest of the parasite's growth and cures malaria in a mouse model. We present here a detailed study that reveals a mode of action for two P. falciparum choline kinase inhibitors both in vitro and in vivo. The compounds present distinct binding modes to the choline/ethanolamine-binding site of P. falciparum choline kinase, reflecting different types of inhibition. Strikingly, these compounds primarily inhibit the ethanolamine kinase activity of the P. falciparum choline kinase, leading to a severe decrease in the phosphatidylethanolamine levels within P. falciparum, which explains the resulting growth phenotype and the parasites death. These studies provide an understanding of the mode of action, and act as a springboard for continued antimalarial development efforts selectively targeting P. falciparum choline kinase.


Asunto(s)
Antimaláricos/farmacología , Colina Quinasa/antagonistas & inhibidores , Fosfatidiletanolaminas/biosíntesis , Plasmodium falciparum/enzimología , Proteínas Protozoarias/antagonistas & inhibidores , Antimaláricos/química , Dominio Catalítico , Células Cultivadas , Colina Quinasa/química , Colina Quinasa/metabolismo , Cristalografía por Rayos X , Evaluación Preclínica de Medicamentos , Eritrocitos/parasitología , Humanos , Concentración 50 Inhibidora , Cinética , Modelos Moleculares , Plasmodium falciparum/efectos de los fármacos , Unión Proteica , Proteínas Protozoarias/química , Proteínas Protozoarias/metabolismo , Trofozoítos/efectos de los fármacos , Trofozoítos/enzimología
13.
Biomed Res Int ; 2016: 1645097, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27525262

RESUMEN

Plasmodium falciparum mitogen-activated protein (MAP) kinases, a family of enzymes central to signal transduction processes including inflammatory responses, are a promising target for antimalarial drug development. Our study shows for the first time that the P. falciparum specific MAP kinase 2 (PfMAP2) is colocalized in the nucleus of all of the asexual erythrocytic stages of P. falciparum and is particularly elevated in its phosphorylated form. It was also discovered that PfMAP2 is expressed in its highest quantity during the early trophozoite (ring form) stage and significantly reduced in the mature trophozoite and schizont stages. Although the phosphorylated form of the kinase is always more prevalent, its ratio relative to the nonphosphorylated form remained constant irrespective of the parasites' developmental stage. We have also shown that the TSH motif specifically renders PfMAP2 genetically divergent from the other plasmodial MAP kinase activation sites using Neighbour Joining analysis. Furthermore, TSH motif-specific designed antibody is crucial in determining the location of the expression of the PfMAP2 protein. However, by using immunoelectron microscopy, PPfMAP2 were detected ubiquitously in the parasitized erythrocytes. In summary, PfMAP2 may play a far more important role than previously thought and is a worthy candidate for research as an antimalarial.


Asunto(s)
Núcleo Celular/enzimología , Sistema de Señalización de MAP Quinasas , Plasmodium falciparum/enzimología , Secuencias de Aminoácidos , Animales , Anticuerpos/química , Antimaláricos/uso terapéutico , Biología Computacional , Eritrocitos/parasitología , Técnica del Anticuerpo Fluorescente Indirecta , Regulación Enzimológica de la Expresión Génica , Humanos , Malaria Falciparum/tratamiento farmacológico , Microscopía Fluorescente , Microscopía Inmunoelectrónica , Fosforilación , Filogenia , Proteínas Protozoarias/fisiología , Conejos , Especificidad por Sustrato , Trofozoítos/enzimología
14.
Biochimie ; 127: 173-86, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27234615

RESUMEN

Homologous recombination (HR) is a highly conserved pathway for the repair of chromosomes that harbor DNA double-stranded breaks (DSBs). The recombinase RAD51 plays a key role by catalyzing the pairing of homologous DNA molecules and the exchange of information between them. Two putative DMC1 homologs (DMC1A and DMC1B) have been identified in Giardia duodenalis. In terms of sequences, GdDMC1A and GdDMC1B bear all of the characteristic recombinase domains: DNA binding domains (helix-turn-helix motif, loops 1 and 2), an ATPcap and Walker A and B motifs associated with ATP binding and hydrolysis. Because GdDMC1B is expressed at the trophozoite stage and GdDMC1A is expressed in the cyst stage, we cloned the giardial dmc1B gene and expressed and purified its protein to determine its activities, including DNA binding, ATP hydrolysis, and DNA strand exchange. Our results revealed that it possessed these activities, and they were modulated by divalent metal ions in different manners. GdDMC1B expression at the protein and transcript levels, as well as its subcellular localization in trophozoites upon DNA damage, was assessed. We found a significant increase in GdDMC1B transcript and protein levels after ionizing radiation treatment. Additionally, GdDMC1B protein was mostly located in the nucleus of trophozoites after DNA damage. These results indicate that GdDMC1B is the recombinase responsible for DSBs repair in the trophozoite; therefore, a functional Rad51 role is proposed for GdDMC1B.


Asunto(s)
Reparación del ADN , Giardia lamblia/enzimología , Giardia lamblia/genética , Recombinasa Rad51/metabolismo , Trofozoítos/enzimología , Secuencia de Aminoácidos , Daño del ADN , ADN de Cadena Simple/metabolismo , Regulación Enzimológica de la Expresión Génica , Modelos Moleculares , Nucleoproteínas/metabolismo , Dominios Proteicos , Recombinasa Rad51/química , Recombinasa Rad51/genética , Trofozoítos/metabolismo
15.
Sci Rep ; 6: 21802, 2016 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-26902486

RESUMEN

Epigenetic control via reversible histone methylation regulates transcriptional activation throughout the malaria parasite genome, controls the repression of multi-copy virulence gene families and determines sexual stage commitment. Plasmodium falciparum encodes ten predicted SET domain-containing protein methyltransferases, six of which have been shown to be refractory to knock-out in blood stage parasites. We have expressed and purified the first recombinant malaria methyltransferase in sufficient quantities to perform a full enzymatic characterization and reveal the ill-defined PfSET7 is an AdoMet-dependent histone H3 lysine methyltransferase with highest activity towards lysines 4 and 9. Steady-state kinetics of the PfSET7 enzyme are similar to previously characterized histone methyltransferase enzymes from other organisms, however, PfSET7 displays specific protein substrate preference towards nucleosomes with pre-existing histone H3 lysine 14 acetylation. Interestingly, PfSET7 localizes to distinct cytoplasmic foci adjacent to the nucleus in erythrocytic and liver stage parasites, and throughout the cytoplasm in salivary gland sporozoites. Characterized recombinant PfSET7 now allows for target based inhibitor discovery. Specific PfSET7 inhibitors can aid in further investigating the biological role of this specific methyltransferase in transmission, hepatic and blood stage parasites, and may ultimately lead to the development of suitable antimalarial drug candidates against this novel class of essential parasite enzymes.


Asunto(s)
N-Metiltransferasa de Histona-Lisina/metabolismo , Histonas/metabolismo , Plasmodium falciparum/enzimología , Proteínas Protozoarias/metabolismo , Esporozoítos/enzimología , Trofozoítos/enzimología , Secuencia de Aminoácidos , Animales , Anopheles/parasitología , Baculoviridae/genética , Baculoviridae/metabolismo , Clonación Molecular , Epigénesis Genética , Eritrocitos/parasitología , Eritrocitos/ultraestructura , Expresión Génica , N-Metiltransferasa de Histona-Lisina/genética , Histonas/genética , Humanos , Cinética , Hígado/citología , Hígado/parasitología , Mutación , Plasmodium falciparum/genética , Plasmodium falciparum/ultraestructura , Proteínas Protozoarias/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Glándulas Salivales/parasitología , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Células Sf9 , Spodoptera , Esporozoítos/ultraestructura , Especificidad por Sustrato , Trofozoítos/ultraestructura
16.
J Biol Chem ; 291(8): 3860-70, 2016 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-26697886

RESUMEN

Protein modification by small ubiquitin-related modifiers (SUMOs) is essential and conserved in the malaria parasite, Plasmodium falciparum. We have previously shown that interactions between the SUMO E1-activating and E2-conjugating enzyme in P. falciparum are distinct compared with human, suggesting a potential target for development of parasite-specific inhibitors of SUMOylation. The parasite asexual trophozoite stage is susceptible to iron-induced oxidative stress and is subsequently a target for many of the current anti-malarial drugs. Here, we provide evidence that SUMOylation plays a role in the parasite response to oxidative stress during red blood cell stages, indicative of a protective role seen in other organisms. Using x-ray crystallography, we solved the structure of the human SUMO E1 ubiquitin fold domain in complex with the E2, Ubc9. The interface defined in this structure guided in silico modeling, mutagenesis, and in vitro biochemical studies of the P. falciparum SUMO E1 and E2 enzymes, resulting in the identification of surface residues that explain species-specific interactions. Our findings suggest that parasite-specific inhibitors of SUMOylation could be developed and used in combination therapies with drugs that induce oxidative stress.


Asunto(s)
Modelos Moleculares , Plasmodium falciparum/enzimología , Proteínas Protozoarias/química , Enzimas Ubiquitina-Conjugadoras/química , Humanos , Estrés Oxidativo/fisiología , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Especificidad de la Especie , Sumoilación/fisiología , Trofozoítos/química , Trofozoítos/enzimología , Enzimas Ubiquitina-Conjugadoras/genética , Enzimas Ubiquitina-Conjugadoras/metabolismo
17.
Antimicrob Agents Chemother ; 59(11): 7128-31, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26324270

RESUMEN

The methionyl-tRNA synthetase (MetRS) is a novel drug target for the protozoan pathogen Giardia intestinalis. This protist contains a single MetRS that is distinct from the human cytoplasmic MetRS. A panel of MetRS inhibitors was tested against recombinant Giardia MetRS, Giardia trophozoites, and mammalian cell lines. The best compounds inhibited trophozoite growth at 500 nM (metronidazole did so at ∼5,000 nM) and had low cytotoxicity against mammalian cells, indicating excellent potential for further development as anti-Giardia drugs.


Asunto(s)
Antiprotozoarios/farmacología , Giardia lamblia/efectos de los fármacos , Metionina-ARNt Ligasa/antagonistas & inhibidores , Trofozoítos/efectos de los fármacos , Giardia lamblia/enzimología , Metronidazol/farmacología , Trofozoítos/enzimología
18.
PLoS Pathog ; 11(3): e1004666, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25730114

RESUMEN

The protozoan parasite Entamoeba histolytica causes a wide spectrum of intestinal infections. In severe cases, the trophozoites can breach the mucosal barrier, invade the intestinal epithelium and travel via the portal circulation to the liver, where they cause hepatic abscesses, which can prove fatal if left untreated. The host Extra Cellular Matrix (ECM) plays a crucial role in amoebic invasion by triggering an array of cellular responses in the parasite, including induction of actin rich adhesion structures. Similar actin rich protrusive structures, known as 'invadosomes', promote chemotactic migration of the metastatic cancer cells and non-transformed cells by remodeling the ECM. Recent studies showed a central role for Rab GTPases, the master regulators of vesicular trafficking, in biogenesis of invadosomes. Here, we showed that fibronectin, a major host ECM component induced actin remodeling in the parasite in a Rab21 dependent manner. The focalized actin structures formed were reminiscent of the mammalian invadosomes. By using various approaches, such as immunofluorescence confocal microscopy and scanning electron microscopy, along with in vitro invasion assay and matrix degradation assay, we show that the fibronectin induced formation of amoebic actin dots depend on the nucleotide status of the GTPase. The ECM components, fibronectin and collagen type I, displayed differential control over the formation of actin dots, with fibronectin positively and collagen type I negatively modulating it. The cell surface adhesion molecule Gal/GalNAc complex was also found to impose additional regulation on this process, which might have implication in collagen type I mediated suppression of actin dots.


Asunto(s)
Actinas/metabolismo , Entamoeba histolytica , Fibronectinas/metabolismo , Proteínas Protozoarias , Proteínas de Unión al GTP rab , Entamoeba histolytica/enzimología , Entamoeba histolytica/genética , Entamoeba histolytica/patogenicidad , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Trofozoítos/enzimología , Proteínas de Unión al GTP rab/genética , Proteínas de Unión al GTP rab/metabolismo
19.
Antimicrob Agents Chemother ; 58(12): 7072-82, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25223993

RESUMEN

Giardiasis is highly prevalent in the developing world, and treatment failures with the standard drugs are common. This work deals with the proposal of omeprazole as a novel antigiardial drug, focusing on a giardial glycolytic enzyme used to follow the cytotoxic effect at the molecular level. We used recombinant technology and enzyme inactivation to demonstrate the capacity of omeprazole to inactivate giardial triosephosphate isomerase, with no adverse effects on its human counterpart. To establish the specific target in the enzyme, we used single mutants of every cysteine residue in triosephosphate isomerase. The effect on cellular triosephosphate isomerase was evaluated by following the remnant enzyme activity on trophozoites treated with omeprazole. The interaction of omeprazole with giardial proteins was analyzed by fluorescence spectroscopy. The susceptibility to omeprazole of drug-susceptible and drug-resistant strains of Giardia lamblia was evaluated to demonstrate its potential as a novel antigiardial drug. Our results demonstrate that omeprazole inhibits giardial triosephosphate isomerase in a species-specific manner through interaction with cysteine at position 222. Omeprazole enters the cytoplasmic compartment of the trophozoites and inhibits cellular triosephosphate isomerase activity in a dose-dependent manner. Such inhibition takes place concomitantly with the cytotoxic effect caused by omeprazole on trophozoites. G. lamblia triosephosphate isomerase (GlTIM) is a cytoplasmic protein which can help analyses of how omeprazole works against the proteins of this parasite and in the effort to understand its mechanism of cytotoxicity. Our results demonstrate the mechanism of giardial triosephosphate isomerase inhibition by omeprazole and show that this drug is effective in vitro against drug-resistant and drug-susceptible strains of G. lamblia.


Asunto(s)
Antiprotozoarios/farmacología , Inhibidores Enzimáticos/farmacología , Giardia lamblia/efectos de los fármacos , Omeprazol/farmacología , Proteínas Protozoarias/antagonistas & inhibidores , Triosa-Fosfato Isomerasa/antagonistas & inhibidores , Trofozoítos/efectos de los fármacos , Albendazol/farmacología , Cultivo Axénico , Cisteína/química , Cisteína/metabolismo , Relación Dosis-Respuesta a Droga , Resistencia a Medicamentos , Escherichia coli/genética , Escherichia coli/metabolismo , Expresión Génica , Giardia lamblia/enzimología , Giardia lamblia/crecimiento & desarrollo , Giardia lamblia/aislamiento & purificación , Humanos , Metronidazol/farmacología , Mutación , Nitrocompuestos , Pruebas de Sensibilidad Parasitaria , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Espectrometría de Fluorescencia , Tiazoles/farmacología , Triosa-Fosfato Isomerasa/genética , Triosa-Fosfato Isomerasa/metabolismo , Trofozoítos/enzimología , Trofozoítos/crecimiento & desarrollo
20.
Antimicrob Agents Chemother ; 58(8): 4341-52, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24841259

RESUMEN

Radicicol, an antifungal antibiotic, was previously identified as a compound having antimalarial activity. However, its mechanism of action in Plasmodium falciparum was not elucidated. While characterizing its antimalarial function, we observed that radicicol manifested two distinct developmental defects in cultured P. falciparum in a concentration-dependent manner. At a low concentration of radicicol, a significant percentage of drug-treated parasites were arrested at the schizont stage, while at a higher concentration, the parasites were unable to multiply from schizont to ring. Also, the newly formed rings and trophozoites were extremely delayed in development, eventually leading to cell death. We intended to characterize the potential molecular target of radicicol at its sublethal doses. Our results demonstrated that radicicol specifically impaired mitochondrial replication. This decrement was associated with a severalfold increment of the topoisomerase VIB transcript as well as protein in treated cells over that of untreated parasites. Topoisomerase VIB was found to be localized in the organelle fraction. Our docking study revealed that radicicol fits into the Bergerat fold of Pf topoisomerase VIB present in its ATPase domain. Altogether, these data allow us to conclude that P. falciparum topoisomerase VIB might be one of the targets of radicicol causing inhibition of mitochondrial replication. Hence, radicicol can be suitably employed to explore the mitochondrial physiology of malaria parasites.


Asunto(s)
Antimaláricos/farmacología , Macrólidos/farmacología , Recambio Mitocondrial/efectos de los fármacos , Plasmodium falciparum/efectos de los fármacos , Esquizontes/efectos de los fármacos , Proteínas Arqueales/antagonistas & inhibidores , Proteínas Arqueales/química , Proteínas Arqueales/genética , Proteínas Arqueales/metabolismo , ADN-Topoisomerasas de Tipo II/química , ADN-Topoisomerasas de Tipo II/genética , ADN-Topoisomerasas de Tipo II/metabolismo , Relación Dosis-Respuesta a Droga , Eritrocitos/efectos de los fármacos , Eritrocitos/parasitología , Expresión Génica , Humanos , Mitocondrias/efectos de los fármacos , Mitocondrias/enzimología , Mitocondrias/genética , Simulación del Acoplamiento Molecular , Plasmodium falciparum/enzimología , Plasmodium falciparum/genética , Plasmodium falciparum/crecimiento & desarrollo , Conformación Proteica , Proteínas Protozoarias/antagonistas & inhibidores , Proteínas Protozoarias/química , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , ARN Mensajero/antagonistas & inhibidores , ARN Mensajero/genética , ARN Mensajero/metabolismo , Esquizontes/enzimología , Esquizontes/crecimiento & desarrollo , Trofozoítos/efectos de los fármacos , Trofozoítos/enzimología , Trofozoítos/crecimiento & desarrollo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...